Christian O.
- Country
- Germany
- Department
- n.a.
Research Overview
- Evaluation of Long-Term Safety and Tolerability of Tavapadon in Patients with Parkinson's Disease: A 58-Week Open-Label Multinational Study
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of AVP‑786 (deudextromethorphan hydrobromide/quinidine) for Agitation in Alzheimer’s Dementia
- Efficacy and Durability of Ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Phase 3 Study
Data & Insights
Has run more than one trial at 48 of 216 partner sites.
Specializations
Parkinson’s disease and early motor disorder care
Clinical research activity includes therapeutic evaluation in Parkinson’s disease, with attention to early-stage disease management, symptom control, and treatment options aimed at preserving daily function.
- Early Parkinson’s disease
- Motor symptom progression
- Functional impairment
Interest extends to agents used in long-term neurological care and to treatments designed to address worsening movement-related outcomes in adults with evolving parkinsonian syndromes.
Autonomic dysfunction in neurodegenerative disease
The investigator is involved in studies addressing neurogenic orthostatic hypotension, particularly in the setting of multiple system atrophy and related neurodegenerative conditions where blood pressure instability affects safety and mobility.
- Neurogenic orthostatic hypotension
- Multiple system atrophy
- Autonomic symptom burden
This area reflects a therapeutic focus on autonomic symptom relief and cardiovascular support in patients with complex neurological disease.
Migraine prevention and headache disorders
Research involvement covers both episodic migraine and chronic migraine, with emphasis on preventive treatment strategies for adults living with recurrent headache disorders.
- Episodic migraine
- Chronic migraine
- Migraine prevention
Therapeutic interest includes options intended to reduce attack frequency and improve control of persistent migraine-related disability.
Dementia-related agitation and neuropsychiatric symptoms
Clinical trial activity also includes treatment of agitation in dementia of the Alzheimer’s type, focusing on behavioral and neuropsychiatric symptoms that complicate cognitive decline.
- Alzheimer’s disease dementia
- Agitation
- Neuropsychiatric symptoms
This domain highlights involvement in symptom-directed care for patients with dementia-associated behavioral disturbance.
Transdermal neurological therapy
One area of interest includes evaluation of rotigotine patch adherence in Parkinson’s disease, linking neurological treatment with practical aspects of sustained drug delivery through the skin.
- Transdermal treatment
- Patch adhesion
- Neurology-focused drug delivery
This reflects engagement with therapeutic formats relevant to continuous symptom management in movement disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.